We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Intrauterine Surgery Dramatically Boosts Fetal Survival Rate

By HospiMedica International staff writers
Posted on 27 Dec 2011
A new study reveals that fetal tracheal occlusion (FETO) improves infant survival rate in severe cases of congenital diaphragmatic hernia (CDH). More...


Researchers at the University of Sao Paulo (USP; Brazil) conducted a randomized trial between May 2008 and July 2010 to compare the safety and efficacy of FETO for the treatment of severe isolated CDH. In all, 20 patients were assigned randomly to undergo FETO and 21 patients were assigned to no prenatal intervention (control group). FETO was performed under maternal epidural anesthesia supplemented with fetal intramuscular anesthesia; tracheal balloon placement with ultrasound guidance and fetoscopy was completed between 26 and 30 weeks of gestation. The primary outcome was survival to 6 months of age, and other maternal and neonatal outcomes were also evaluated.

The results showed that delivery occurred at a mean 35.6 weeks in the FETO group and at 37.4 weeks in the control group. In all, 50% of the infants in the FETO group and one infant out of 21 (4.8%) in the control group survived, a ten-fold increase in infant survival rate. According to the researchers, the FETO procedure appears to improve survival by enhancing pulmonary growth as a consequence of fetal tracheal occlusion. The study was published in the December 14, 2011, issue of Ultrasound in Obstetrics & Gynecology.

“The present study allows the establishment of this treatment as standard care for severe forms of congenital diaphragmatic hernia,” concluded lead author Rodrigo Ruano, MD, PhD, and colleagues of the department of obstetrics and gynecology.

CDH is a congenital malformation of the diaphragm that allows the abdominal organs to enter the chest cavity and interfere with proper lung formation. The most common type of CDH is a Bochdalek hernia; other types include Morgagni's hernia, diaphragm eventration, and central tendon defects of the diaphragm. CDH is a life-threatening pathology in infants, and a major cause of death due to two complications: pulmonary hypoplasia and pulmonary hypertension. Newborns with CDH often have severe respiratory distress, which can be life threatening unless treated appropriately.

Related Links:
University of Sao Paulo



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.